Multi-omic approach classifies biomarkers for paediatric sepsis
Researchers have discovered potential biomarkers to identify paediatric sepsis progression stage, enabling more targeted treatment.
List view / Grid view
Researchers have discovered potential biomarkers to identify paediatric sepsis progression stage, enabling more targeted treatment.
A new project plans to elucidate the relationship between the glucosylceramidase beta gene and Parkinson’s disease.
The guide provides examples of how Transcreener allowed rapid assay development to enable screening for kinases in innate immune pathways.
AcrlC8 and AcrlC9 prevent the CRISPR-Cas3 machine from binding to its DNA target site, providing a safer way to engineer the genome.
Researchers explored the effects of loops and 3D genome organisation on gene silencing, and found that ‘cohesinopathies’ may be linked it.
Using an AI algorithm to predict glioblastoma’s most active kinase, researchers hope for a next-generation precision therapy targeting resistant cancers.
Dr Ketan Patel, Clarivate, shares his insights about the use of Real-World Data and genomic biomarker data and discusses how researchers can use these to better detect and diagnose diseases.
Disruptions in TP53 and RB1 are key influencers that cause changes in the risk of mutations across chromosomes.
Data from protein analyses, combined with data from patient journals, enabled the discovery of proteins that predict disease progression.
In this guide, we provide an overview of the DDR and innate immune pathway and describe Transcreener Assays and Assay Systems for key targets.
Researchers have developed a new PROTAC that activates the protein degradation system and binds to a previously inaccessible ligase.
21 December 2023 | By
A new Drug Target Review issue is now ready to download! This issue features articles on CRISPR, personalised medicine and screening.
Findings of rare CRISPR-linked gene modules and a novel CRISPR-Cas system have promising implications for genomic therapeutics.
iPS-cell-derived microglia in brain organoids have enabled scientists to understand early brain development and microglia-associated disease.
A new discovery about a different protective genetic mutation in apolipoprotein L1 could have major implications for kidney health.